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Friendly Fire: Biological Functions and Consequences of
Chromosomal Targeting by CRISPR-Cas Systems
Gary E. Heussler, George A. O’Toole
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA
Clustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas) systems in bacteria and archaea target for-
eign elements, such as bacteriophages and conjugative plasmids, through the incorporation of short sequences (termed spacers)
from the foreign element into the CRISPR array, thereby allowing sequence-specific targeting of the invader. Thus, CRISPR-Cas
systems are typically considered a microbial adaptive immune system. While many of these incorporated spacers match targets
on bacteriophages and plasmids, a noticeable number are derived from chromosomal DNA. While usually lethal to the self-tar-
geting bacteria, in certain circumstances, these self-targeting spacers can have profound effects in regard to microbial biology,
including functions beyond adaptive immunity. In this minireview, we discuss recent studies that focus on the functions and
consequences of CRISPR-Cas self-targeting, including reshaping of the host population, group behavior modification, and the
potential applications of CRISPR-Cas self-targeting as a tool in microbial biotechnology. Understanding the effects of CRISPR-
Cas self-targeting is vital to fully understanding the spectrum of function of these systems.
Bacteria and archaea are under constant threat of viral preda-tion and have evolved numerous mechanisms to defend
against infection (1, 2). One such mechanism is the clustered reg-
ularly interspaced short palindromic repeat (CRISPR)-associated
(Cas) protein system, which provides adaptive immunity against
viruses and plasmids, collectively referred to as mobile genetic
elements (MGEs) (3–5). While many divergent CRISPR-Cas sys-
tems exist, currently divided into 6 distinct types (6, 7), their gen-
eral function is conserved. A CRISPR array is composed of short
repeat sequences flanking unique spacer inserts transcribed by a
promoter found in an adjacent AT-rich sequence (termed the
leader) into a long precursor RNA molecule known as pre-
CRISPR RNA (pre-crRNA). This pre-CRISPR RNA transcript is
processed into multiple RNA molecules, known as mature crRNA,
through nucleolytic cleavage at specific sequences in the repeats,
with one exception being the type II-C system, in which mature
crRNA is generated through transcription from promoters in each
CRISPR (8). The mature crRNA then associates with Cas proteins
to form the targeting CRISPR ribonucleoprotein complex (9, 10).
The crRNA molecule is critical in host defense against MGEs,
since the transcribed spacer provides the specificity of its target,
and once bound through Watson-Crick base pairing, results in
either degradation (type I) or cleavage (types II-VI) of the target
through Cas protein nuclease activity.
The incorporation of a short sequence (usually 30 to 40 bp)
from the invading MGE into the CRISPR array as a new spacer is
a process termed CRISPR adaptation, a key step in CRISPR adap-
tive immunity. Analysis of the sequences of spacers from a given
CRISPR array can serve as a history of previous CRISPR-Cas in-
teractions with invading MGEs. The first evidence that CRISPR-
Cas systems function as an immune system came from such an
analysis, when in 2005, three separate groups examined a variety
of CRISPR arrays and found that spacers matched sequences
found in phages and plasmids (11–13). However, in addition to
the matches with MGEs, spacers were also found that target sites
on the bacterial or archaeal genome. For example, in Yersinia spp.,
of 36 spacers analyzed, the majority were of bacteriophage origin,
but 8 spacers matched sequences on the Yersinia chromosome
(13). A similar pattern was observed in a broader analysis of 4,500
spacers across archaea and bacteria, in which 35% of the spacers
that matched sequences in the NCBI database were derived from
chromosomal DNA and apparently were not related to foreign
elements or prophages (12). Since these early observations, self-
targeting spacers have consistently been found in CRISPR arrays
(14–19), demonstrating that the insertion of a self-targeting
spacer is not a rare event.
Given that at least one of the six types of CRISPR-Cas systems
are present in 84% and 45% of sequenced archaeal and bacterial
genomes, respectively (20), it is clear that these systems are as
widespread as they are diverse. As research on these systems ex-
pands, and since a surprisingly large percentage of CRISPR spac-
ers have been shown to have sequence identity to bacterial chro-
mosomal targets, it is becoming clear that CRISPR-Cas systems
can play a role in biological functions beyond adaptive immunity
(21) and that self-targeting spacers can, at least in part, drive these
alternative functions. This review aims to summarize current re-
search on CRISPR-Cas self-targeting in prokaryotes and the role
these events can play in important biological functions.
SELF-TARGETING WITH 100% COMPLEMENTARITY CAN
DRIVE EVOLUTION
The most likely outcome of a 100% complementary, self-targeting
spacer is cell death (Fig. 1A); such events have been experimentally
demonstrated in multiple CRISPR-Cas types (22–24). For this
reason, there are mechanisms that prevent a spacer from targeting
the CRISPR array from which it was transcribed, such as the re-
quirement of a protospacer adjacent motif (PAM) in the type I, II,
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V, and VI systems (25) or inactivation of the targeting CRISPR
ribonucleoprotein complex through base pairing between the 5=
handle of the crRNA and the CRISPR repeats in the type III system
(26). However, these mechanisms would not prevent cell death if
a spacer is acquired that targets the host chromosome, and accord-
ingly, evidence from the type I-E system of Escherichia coli suggests
that the bacteria have evolved to preferentially sample foreign
DNA over chromosomal DNA during naive CRISPR adaptation.
It was observed previously in CRISPR adaptation studies using E.
coli as a model system that the cell is roughly 100 to 1,000 times
more likely to incorporate plasmid DNA over chromosomal DNA
into its CRISPRs after normalizing for their respective size (27,
28). Recent evidence suggests one such mechanism for this pref-
erential incorporation of foreign DNA into CRISPR regions dur-
ing naive CRISPR adaptation is the involvement of the RecBCD
complex. During DNA replication, when a double-stranded break
occurs, RecBCD participates in the generation of single-stranded
DNA, which can serve as a substrate for spacer acquisition by the
Cas1-Cas2 complex. Chi sites, which are 8-nucleotide motifs well
represented in the E. coli genome, limit the extent of single-
stranded DNA generated by the RecBCD complex, and it was
found the CRISPR-Cas system avoids the acquisition of DNA near
Chi sites (27). Therefore, the lower prevalence of Chi sites on
plasmids versus the E. coli genome, along with the preference of
RecBCD to degrade linear DNA, such as recently injected phage
DNA, might explain the observed preferential incorporation of
foreign DNA. Cas1 has been shown to physically interact with
RecB and RecC (29), and recently, a second group confirmed the
requirement of the RecBCD complex during naive CRISPR adap-
tation in E. coli (30), further supporting this model.
Nevertheless, the frequency at which self-targeting spacers are
found in CRISPR arrays suggests that, although less common than
the incorporation of foreign DNA, incorporation of a self-target-
ing spacer can occur, perhaps impacting the biology of the host
bacterial cell. This idea was directly tested in Pectobacterium atro-
septicum. The native CRISPR2 array of P. atrosepticum contains a
self-targeting spacer 100% complementary to a chromosomal
gene within an 100-kb horizontally acquired island named
HAI2, but CRISPR lethality is abrogated due to a nonconsensus
PAM (22). To assay the consequences of CRISPR self-targeting, P.
atrosepticum was transformed with an inducible plasmid contain-
ing a truncated type I-F CRISPR1 leader, appropriate repeats, and
an engineered spacer targeting the same gene in HAI2 as the native
spacer but with the correct PAM. Induction of the self-targeting
spacer-containing plasmid resulted in a cessation of bacterial
growth and elongation of the bacterial cell indicative of DNA
damage and the subsequent SOS response, confirming that a self-
targeting spacer is cytotoxic (22). Interestingly, when the bacteria
were left for 36 h, suppressor mutants arose in which CRISPR
targeting was ablated, including deletions of the chromosomal
FIG 1 Consequences of CRISPR self-targeting in the type I system. The self-targeting crRNA can be transcribed from either the native CRISPR array or an
artificial array on a plasmid, and the crRNA associates with the Cas proteins expressed from the native Cas-encoding operon to form the self-targeting crRNA
ribonucleoprotein complex. These self-targeting spacers include both 100% complementary spacers (purple and yellow), as well as partially matching spacers
(green and black). The most likely outcome of a 100% complementary match is cell death (A) due to the nucleolytic activity of the CRISPR-Cas system; however,
this results in strong selection for mutants that remove the targeted region, for example, by genome rearrangement, such as excision of pathogenicity island or
curing of a prophage (B). A partially matching self-targeting spacer can modulate group behavior, such as biofilm formation, by triggering viable planktonic cells
(green cells) to die (red cells) upon surface binding (C). Bacterial populations transformed with a plasmid containing an artificial self-targeting spacer can enrich
for bacterial strains that do not contain the target on their genome (purple cells, D).
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target. The size of the deletion differed between the mutants and
included excision of the entire 100-kb HAI2 island. A similar
effect was observed when the spacer was designed to target a core
region of the genome instead of HAI2, demonstrating that while a
self-targeting spacer will normally result in cell death, it can also
reshape the bacterial genome. Furthermore, these findings show
that self-targeting is not dependent on the target being horizon-
tally acquired, such as the integrative conjugative element HAI2.
A similar result was demonstrated using the native type II-A
CRISPR-Cas system of Streptococcus thermophilus. When S. ther-
mophilus was transformed with a plasmid carrying genes encoding
artificial spacers targeting genomic islands within the transformed
strain, 99% of the transformed bacteria were killed, but the sur-
viving transformants contained large deletions of the targeted re-
gions (31). The authors showed that the deletions were the result
of recombination between insertion sequence elements (IS) on
the S. thermophilus chromosome flanking the targeted region, and
that the IS-dependent recombination events were occurring at a
low frequency in the wild-type population. Taken together, these
data indicate that the incorporation of a self-targeting spacer can
drive evolution, but likely through selection of a small population
of bacteria in which excision of the targeted region has occurred
naturally (Fig. 1B).
SELF-TARGETING WITH 100% COMPLEMENTARITY CAN
SELECT FOR PROPHAGE-CURED BACTERIA
When a bacterium is lysogenized by a particular phage, the phage
genome is for all intents and purposes part of the bacterial ge-
nome. Thus, another potential benefit of a self-targeting spacer is
its ability to incorporate a spacer targeting the prophage, which
will reshape a bacterial population by selecting for cells that have
excised the prophage from their chromosome (Fig. 1B). This no-
tion was tested in an hns mutant strain of E. coli in which the native
CRISPR system, normally heat-stable nucleoid-structuring (H-
NS) silenced, was active. The E. coli strain harboring a lambda
phage with a temperature-sensitive cI gene allowing controlled
lytic induction was transformed with an inducible plasmid con-
taining either an artificial spacer targeting the prophage or a con-
trol spacer with no target. Upon simultaneous induction of both
the prophage and the artificial spacer-containing plasmid, the ma-
jority of cells (99%) were killed; however, the survival frequency
of cells transformed with the prophage-targeting spacer was 500-
fold higher than the survival frequency of cells transformed with
the control spacer (32). These data suggest that the CRISPR-Cas
system, under the right circumstances, can select for cells that have
excised the phage.
The ability to select for cells that have cured a prophage is likely
not limited to E. coli. In Streptococcus pyogenes, 13 sequenced
strains were assayed for CRISPR arrays, and of the 8 CRISPR-
positive strains, 41 distinct spacers were identified, with 26 spacers
found to target S. pyogenes prophages. However, no strain con-
tained a spacer targeting a prophage on its own genome (33).
Additionally, it was found the CRISPR-negative strains contained
significantly more prophages than the CRISPR-positive strains,
and furthermore, within the 8 CRISPR-positive S. pyogenes
strains, an inverse correlation was found between the number of
spacers per genome and the number of prophages within each
genome. Similarly, recently, the CRISPR-Cas systems of the genus
Bifidobacterium were analyzed, and 25 out of 32 characterized type
I and type II CRISPR-Cas systems contained at least one spacer
sequence targeting a Bifidobacterium lysogenic prophage, includ-
ing two instances in which the Bifidobacterium species included a
spacer targeting a prophage on its own genome (16). Similar to S.
pyogenes, a positive correlation was found between strains lacking
a CRISPR-Cas system and the number of times prophages were
found on the chromosome targeted by spacers in other Bifidobac-
terium CRISPR-Cas systems. For example, Bifidobacterium angu-
latum contains 26 unique spacers that target prophages on 11
other Bifidobacterium species genomes while harboring no spacer-
targeted prophages on its own genome.
Additionally, a bioinformatic analysis of 365 Pseudomonas
aeruginosa CRISPR-Cas systems from 672 sequenced P. aerugi-
nosa strains found that 55% of the 2,823 unique spacers matched
sites in the P. aeruginosa genome, the vast majority of which are
predicted to target the P. aeruginosa accessory genome, including
potential prophages (17). The P. aeruginosa strains lacking
CRISPR-Cas systems were on average 300 kbp larger than those
with a CRISPR-Cas system. Thus, it is possible the CRISPR-Cas
systems of S. pyogenes, Bifidobacterium spp., and P. aeruginosa are
either actively preventing the uptake of MGEs (including pro-
phages) or incorporating self-targeting spacers that select for cells
that have purged these MGEs in a manner analogous to the exper-
imentally demonstrated removal of genomic regions in P. atrosep-
ticum (22) and S. thermophilus (31).
SELF-TARGETING WITH 100% COMPLEMENTARITY IN THE
TYPE III-A SYSTEM CAN HELP MICROBES TOLERATE
TEMPERATE PHAGES BY BLOCKING THE ENTRY OF
PROPHAGES INTO THE LYTIC CYCLE
While the presence of a lysogenic phage on a bacterial chromo-
some can be detrimental to bacterial fitness (34), it has been well
established that prophages can provide beneficial functions to,
and increase the fitness of, the bacterial host (35, 36). For this
reason, curing a phage from the bacterial chromosome can have a
selective disadvantage. Unlike the type I and II systems discussed
above, a type III-A/B CRISPR-Cas array can potentially include
a self-targeting spacer without associated cytotoxicity due to
general transcription-dependent targeting of the type III-A/B
systems (37–39).
A recent study of Staphylococcus aureus showed that when
spacers targeted lytic genes silenced during lysogeny, no CRISPR
interference through the type III-A system was detected. CRISPR
interference could only be achieved when the target gene was ex-
pressed; this finding was demonstrated by integrating a CRISPR-
targeted gene under the control of a tightly regulated inducible
promoter on the S. aureus chromosome. This strain was then
transformed with a plasmid expressing the spacer targeting the
integrated gene, and CRISPR interference was detected only upon
induction of the chromosomal promoter driving expression of the
targeted gene. Additionally, only spacers targeting the nontem-
plate strand of the targeted gene can generate CRISPR interfer-
ence, illustrating transcription-dependent targeting, and further-
more, distinguishing the targeting requirements of the type III
system from the type I and II systems (37, 40). The implication of
these findings is that bacteria with spacers capable of self-targeting
a prophage can tolerate a 100% complementary self-match and
reap the putative benefits of a prophage while also preventing
phage-mediated lysis.
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SELF-TARGETING WITH PARTIAL COMPLEMENTARITY CAN
DRIVE GROUP BEHAVIOR
The research discussed so far has focused on the interaction of a
spacer that is 100% complementary with a DNA target on (or
associated with) the host chromosome, but a partially matching
spacer can still elicit an effect without the lethality typically asso-
ciated with a 100% complementary spacer. Generally, partially
matching spacers are thought to be important in CRISPR priming,
in which the presence of a spacer partially matching an MGE will
greatly increase the likelihood of incorporating new spacers
against the MGE, and particularly sequences that match regions
adjacent to the partially matched target (41–45). Additionally, it
was recently found that spacers with a mismatch in regions con-
sidered indispensable for CRISPR interference, such as the seed
sequence or PAM, may still be capable of functioning directly in
CRISPR-mediated interference (46). Therefore, self-targeting
spacers with partial complementarity can likely still drive biolog-
ical functions.
The best example of a partially complementary spacer impact-
ing microbial behavior is the modification of group behavior by
the type I-F CRISPR-Cas system in P. aeruginosa. When P. aerugi-
nosa is lysogenized by the bacteriophage DMS3, the interaction of
a partially complementary spacer encoded by the P. aeruginosa
CRISPR2 array with a target on the DMS3 prophage inhibits bio-
film formation and swarming motility, two group behaviors im-
portant for virulence (47, 48). These altered biofilm and swarming
phenotypes are dependent on the nickase activity of the effector
protein Cas3, since a mutation in the catalytic region of the nu-
clease domain of Cas3 fully restores biofilm formation and
swarming motility (48). The 2 mismatches at the 9 and 11
positions on the spacer prevent a lethal self-targeting event but
promote sufficient CRISPR targeting activity to induce RecA,
which in turn directly induces the expression of SOS-regulated,
phage-related autolysis genes that induce cell death upon the bac-
teria attaching to a surface. Induction of the phage-related autol-
ysis genes effectively inhibits biofilm and swarming motility
through death of the surface-associated bacteria while having no
noticeable effect on the planktonic population (Fig. 1C) (49).
Given that numerous P. aeruginosa Mu-like phages contain the
same protospacer target as DMS3 (50, 51), it is unclear if this
interaction was directly selected or simply a side effect of CRISPR-
Cas immunity. Nevertheless, the demonstration that a partially
matching spacer can elicit such a strong biological response, in
combination with the frequency of self-targeting spacers present
in CRISPR arrays across both bacteria and archaea, suggests the
potential of other partial matching interactions impacting impor-
tant aspects of bacterial biology. It is unlikely that the biological
impact of partial complementarity of a CRISPR spacer is limited
to P. aeruginosa.
SELF-TARGETING CAN BE EXPLOITED FOR USE IN
BIOTECHNOLOGY
CRISPR-Cas research has received a great deal of attention, largely
for use of the type II system (52, 53) and the recently described
type V system (54), in the genetic engineering of eukaryotic sys-
tems. Recent work has demonstrated that CRISPR-Cas technol-
ogy is not limited to the engineering of eukaryotic systems and can
be used in bacterial and archaeal systems as well. For example, for
the type I-E system, it has been shown that E. coli lacking the
effector enzyme Cas3 can be transformed with plasmids harboring
self-targeting spacers without lethal effects, and designing these
spacers to target the promoter of a particular gene will result in
silencing of that particular gene due to the binding of the Cascade
complex (55, 56). Exploiting CRISPR-Cas systems for such engi-
neering approaches is likely not limited to the type I-E system and
would potentially allow the endogenous type I systems of any
number of bacteria to be coopted for CRISPR-mediated genetic
control. Such approaches may be particularly useful in nonmodel
organisms.
As another example, it has been shown that the cytotoxic ef-
fects of CRISPR self-targeting, such as those described earlier (22),
can be used to remove particular strains of bacteria from a popu-
lation. A mixed but equal population of E. coli K-12 and E. coli B,
which share 99% sequence identity, was transformed with plas-
mids harboring self-targeting spacers unique to either sequences
of strain K-12 or B (Fig. 1D), and the resulting transformants were
composed almost entirely of the nontargeted strain (99.9%) due
to CRISPR interference from the self-targeting spacers (57). This
cytotoxicity is the basis of “CRISPR antimicrobials,” in which an-
tibiotic strains of a particular bacterial species, including E. coli
(58) and S. aureus (59), are selected out of a population through
CRISPR self-targeting of antibiotic resistance genes.
CONCLUSIONS AND FUTURE PERSPECTIVES
While the incorporation of a self-targeting spacer into a CRISPR
array is typically a lethal event for a microbe, the surprisingly high
frequency of self-targeting spacers identified from sequenced
CRISPR arrays indicates that the occurrence of CRISPR-Cas self-
targeting is not rare in nature. Self-targeting spacers with 100%
complementarity in a type I or II system present the microbe with
the challenge of avoiding CRISPR-induced lethality, which can
reshape bacterial populations by selecting for bacteria in which
genome rearrangement has occurred, such as excising pathoge-
nicity islands or curing of a prophage. There are several examples
in bacteria in which CRISPR-positive strains have a smaller ge-
nome than that of CRISPR-negative strains, and it is unclear if the
reduction in genome size (specifically MGEs) is the result of the
CRISPR-Cas system actively preventing the acquisition of MGEs
or if incorporation of self-targeting spacers is selecting for bacteria
in the population that have purged their genome of any of these
invading sequences. It is important to note that microbes contain-
ing a type III CRISPR system are more tolerant of self-targeting
spacers, since target transcription is required for CRISPR interfer-
ence, allowing the microbe to tolerate a prophage when the tar-
geted gene is silenced, which is the case for most phage genes
during lysogeny.
Self-targeting is not limited to 100% complementary spacers; a
self-targeting spacer can still have meaningful biological conse-
quences even with multiple mismatches between the spacer and its
genomic target, such as group behavior modification in P. aerugi-
nosa. This is a largely unexplored area of research, and with the
sheer number of potential partially matching spacers already iden-
tified in bacterial genomes, it is tempting to speculate that other
microbial behaviors can be attributed to CRISPR self-targeting,
especially in light of recent studies demonstrating functional
CRISPR interference even with multiple mutations disrupting
spacer-protospacer complementarity (46, 60). This is a largely un-
explored area of research.
Overall, we are only beginning to understand the role of
CRISPR self-targeting, and with the diversity of CRISPR-Cas
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types and variety of biological consequences of a self-targeting
spacer that were already demonstrated, chromosomal-targeting
spacers are gaining attention. It will be exciting to see future ad-
vances in our understanding of the biological functions and con-
tinued applications of CRISPR self-targeting in biotechnology.
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